Waldencast plc, a prominent player in the beauty and wellness sector, has recently announced a significant shift in its corporate strategy. The company, known for its dedication to developing, acquiring, and scaling purpose-driven skincare and beauty products, has filed a Form 25 with the U.S. Securities and Exchange Commission (SEC). This filing marks the beginning of a process to remove its Class A ordinary shares and associated redeemable warrants from listing on the Nasdaq exchange. The company anticipates the last trading day on Nasdaq to occur in early October, with the deregistration of these securities under the Exchange Act becoming effective approximately 90 days following the filing.
This strategic move is indicative of Waldencast’s intention to alter its regulatory and reporting framework. By removing its shares from Nasdaq, Waldencast aims to streamline its operations and potentially reduce the regulatory burdens associated with being a publicly traded company. The company has also indicated that it may file a Form 15 shortly after the deregistration, which would suspend its reporting obligations under the Exchange Act. This step would further simplify its compliance requirements and allow the company to focus more on its core mission of catering to the growing demand for conscious, high-quality cosmetics products worldwide.
Waldencast’s decision to deregister its securities is not set in stone. The company has stated that it may postpone or withdraw the filings if circumstances change, and it will continue to provide updates as required by Nasdaq listing standards and applicable law. This flexibility suggests that Waldencast is carefully considering its options and is prepared to adapt its strategy as needed.
Financially, Waldencast has experienced fluctuations in its stock price over the past year. As of September 24, 2026, the close price of its shares was $1.03, a significant decrease from its 52-week high of $3.22 on November 19, 2025. The company’s shares reached a 52-week low of $0.72 on April 29, 2026. Despite these fluctuations, Waldencast maintains a market capitalization of approximately $132.1 million. The company’s price-to-earnings ratio stands at -0.51, reflecting its current financial performance and market valuation.
Waldencast’s strategic decision to deregister its securities and potentially suspend its reporting obligations under the Exchange Act is a pivotal moment for the company. As it navigates this transition, Waldencast remains committed to its mission of providing high-quality, purpose-driven beauty products to consumers worldwide. The company’s ability to adapt and evolve in response to changing market conditions will be crucial as it continues to grow and expand its presence in the beauty and wellness industry.
